Emotional support a focus of new guidelines to manage constipation
A new set of guidelines, developed by a team of scientists in China, outline ways healthcare professionals can help people…
Articles by Marisa Wexler, MS
Aspirin, ibuprofen don’t affect Parkinson’s progression, data show
The use of over-the-counter pain medicines like ibuprofen and aspirin do not appear to influence the clinical progression of…
Podcast about Parkinson’s and daily life aims to guide nursing students
An informational podcast aims to instruct nursing students in Parkinson’s disease, helping them to feel more empathy for patients…
FDA asked again to approve apomorphine pump SPN-830
Supernus Pharmaceuticals has asked the U.S. Food and Drug Administration (FDA) again to approve the apomorphine infusion pump…
Toxic alpha-synuclein protein seen to alter energy use in nerve cells
Toxic clumps of the protein alpha-synuclein change the way the brain cells most affected by Parkinson’s disease utilize energy,…
Patent given for new approach to Parkinson’s stem cell therapy
Mark Denham, PhD, a scientist in Denmark, has been awarded a patent that covers a new way of using stem…
Dosing begins in trial of potential therapy for GBA1 Parkinson’s
Dosing has begun in a Phase 1 clinical trial that is testing GT-02287, an experimental oral medication being developed to…
Healthy brain region works OT to control Parkinson’s symptoms: Study
In people with Parkinson’s disease, the cerebral cortex of the brain can compensate for disease-related dysfunction in the basal…
DDC enzyme may be biomarker of Parkinson’s, related diseases
Measuring levels of an enzyme called DOPA decarboxylase (DDC) in the blood or fluid around the brain and spinal cord…
Alpha-synuclein lifts up at cell membranes; may promote clumping
When the alpha-synuclein protein is present at high concentrations around cellular membranes, it lifts up rather than lying flat against…